by Camille Dagenais | May 23, 2024 | Addictions, cardiac arrest, Chronic Pain, Featured, Toxicology
The North American opioid crisis is rapidly expanding, resulting in unprecedented levels of harm and strain on the healthcare system. The opioid epidemic is not new to ED providers across the country, but the true extent of harm is quite shocking. In Canada, there has...
by Max Zworth, Rebecca Seliga | Mar 9, 2023 | Addictions, Critical Care, Featured, Grand Round Summaries, Infectious Disease, Most Viewed, Resuscitation, Toxicology
The opioid epidemic is not new to ED providers, but many will be shocked to learn about the true extent of the harm caused by opioids in Canada. In the first half of 2022, there were 3556 recorded deaths due to opioid toxicity in Canada. This amounts to 19 deaths...
by Marissa Ukos, Hans Rosenberg, Venkatesh Thiruganasambandamoorthy | Mar 7, 2023 | Addictions, Chronic Pain, Full Article, Journal Club, Urology
Methodology: 2.5/5 Usefulness: 2.5/5 Razi A, et al. Am J Emerg Med. 2022 Aug;58:245-250. Question and Methods: This single-center, RCT of 120 patients with acute renal colic compared pain control and antiemetic use with dexamethasone + ketorolac compared to...
by Alex Viau, Josee Malette, Alex Coutin | Jul 28, 2022 | Addictions, Featured, Grand Round Summaries, Infectious Disease, Infectious Disease, Public health
When it comes to human immunodeficiency virus (HIV) in the ED, the most medically interesting pathology is in the acute presentation of AIDS-defining opportunistic infections. However, due to advances in anti-retroviral therapies (ART), you’re much less likely...
by Julie Ingratta, Alex Coutin | Jul 14, 2022 | Addictions, emergency, Featured, Gastroenterology, Grand Round Summaries, Main page, Public health, Toxicology
With legalization, and increased ease of access to marijuana, there is increased focus on the diagnosis of Cannabinoid Hyperemesis Syndrome, with broader media attention and thus patient awareness to this entity. History: Cannabis (Cannabis sativa spp.) has been...
by Hans Rosenberg | Oct 5, 2020 | Addictions, Journal Club, Toxicology
Methodology: 3/5 Usefulness: 2/5 Anton RF, et al. JAMA Intern Med. 2020 Mar 9;180(5):1-9. Question and Methods: Blinded randomized control trial comparing gabapentin to placebo in reducing the number of heavy drinking days in alcohol use disorder treatment. Findings:...
by Michael Wong, Alex Coutin | Aug 20, 2020 | Addictions, Critical Care, Featured, mental health, psychiatry
In part 1 of this 2-part series, we discussed diagnosis and initial management of alcohol withdrawal. In part 2, we discuss the role of the benzodiazepines on discharge, how to use gabapentin, naltrexone, and communication strategies to optimize discharge to help your...
